Paederus dermatitis in northern Iran: a report of 156 cases
β Scribed by Omid Zargari; Arash Kimyai-Asadi; Fateme Fathalikhani; Mehdi Panahi
- Book ID
- 104463941
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 157 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0011-9059
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background Paederus dermatitis develops when beetles of the genus Paederus (often called rove beetles) are crushed on the skin, releasing the vesicant pederin. These beetles are found in many tropical and subtropical habitats.
Methods We describe 156 patients who presented to a dermatology clinic in the Guilan province of northern Iran during a 6βmonth period (MayβOctober 2001).
Results The peak time of presentation was in September, and the face and neck were the most common sites of involvement. Clinically, the most common presentation comprised geographic erythematous plaques with micropustules. In threeβquarters of patients, more than one lesion was present. Kissing lesions were seen in 5% of cases, and 15% of patients developed diffuse desquamation. The majority of patients resided within 1Β km of rice fields and used fluorescent lighting at home. In half of the cases, another family member was also affected.
Conclusions Paederus dermatitis is a common skin condition in northern Iran. We believe that increased public awareness of this condition can decrease mucocutaneous exposure to pederin.
π SIMILAR VOLUMES
Protein contact dermatitis (PCD) in food handlers is caused by a type I allergy to foods. We report a 17βyearβold meat sorter who presented with hand dermatitis. Patch tests with the standard series were negative. Prick testing was positive with lamb liver, ox liver and a mixture of lamb and beef bl
Eighty-one patients with cancer of the male breast were studied. The majority (79) presented with a mass in the breast and in 8 patients the tumor was found by chance. Two patients presented with serosanguinous discharge. Average duration of symptoms was 11.9 months. Thirty patients had Stage I, 25